Evotec Wins Research Grant to Advance H3 Receptor Antagonist Programme into the Clinic

News   Apr 27, 2010

 
Evotec Wins Research Grant to Advance H3 Receptor Antagonist Programme into the Clinic
 
 
 

RELATED ARTICLES

Cancer Cells’ Energy Source Blocked by Natural Compound

News

Researchers have not only untangled an unusual wiring system that cancer cells use for carbohydrate metabolism, but also identified a natural compound that appears to selectively shut down this system in laboratory studies.

READ MORE

How do Poison Frogs Protect Themselves Against Their Own Neurotoxin?

News

Scientists are a step closer to resolving a related head-scratcher, how do these frogs keep from poisoning themselves?

READ MORE

Trispecific Antibodies Protect Against HIV

News

A three-pronged antibody made in the laboratory protected monkeys from infection with two strains of SHIV, a monkey form of HIV, better than individual natural antibodies from which the engineered antibody is derived.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE